NVAX — Novavax Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapSucker Stock

Annual balance sheet for Novavax, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	78.8	711	1,515	1,337	569
Net Total Accounts Receivable
Net Total Receivables	7.5	262	455	82.4	297
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	97.2	1,248	2,155	1,703	1,144
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	17.9	188	269	400	491
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	173	1,582	2,577	2,259	1,797
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	25.8	580	2,390	2,460	1,635
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	359	955	2,928	2,893	2,514
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	-186	627	-352	-634	-717
Total Liabilities & Shareholders' Equity	173	1,582	2,577	2,259	1,797
Total Common Shares Outstanding